Chronic hepatitis C: future treatment
Open Access
- 1 January 2014
- journal article
- review article
- Published by Informa UK Limited in Clinical Pharmacology: Advances and Applications
- Vol. 6, 1-17
- https://doi.org/10.2147/CPAA.S30338
Abstract
Peer reviewed article authored by (Wendt A, Adhoute X, Castellani P, Oules V, Ansaldi C, Benali S, Bourlière M). Read article or submit your manuscript for publishing.Keywords
This publication has 39 references indexed in Scilit:
- Epidemiology and natural history of HCV infectionNature Reviews Gastroenterology & Hepatology, 2013
- MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant VariantsAntimicrobial Agents and Chemotherapy, 2012
- Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II studyHepatology, 2012
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1New England Journal of Medicine, 2012
- Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 InfectionsGastroenterology, 2011
- Second-wave Protease Inhibitors: Choosing an HeirClinics in Liver Disease, 2011
- The HCV NS5B Nucleoside and Non-Nucleoside InhibitorsClinics in Liver Disease, 2011
- Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- Genetic variations in heme oxygenase-1 and chronic hepatitisHepatology, 2010
- The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virusHepatology, 2008